XTL Biopharmaceuticals Ltd.

XTLB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.02 (-0.83%)

At close: Sep 21, 2026, 4:00 PM ET

$2.22

-$0.16 (-6.72%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.24M

Enterprise Value $2.38M

Beta 0.45

Average Volume 84.03K

Shares Outstanding (Diluted) 440.1K

Shares Change YoY 29.23%

Institutional Ownership 17.28%

Exchange NASDAQ

ISIN US98386D4060

Price Performance

Price Change 1M -14.4%

Price Change 3M -14.7%

Price Change 6M -12.2%

Price Change YTD -0.8%

Price Change 1Y -50.4%

Price Change 3Y -42.5%

Price Change 5Y -86.1%

1M CAGR (ann.) -16.4%

1Y CAGR (ann.) -50.0%

5Y CAGR (ann.) -33.5%

All-Time CAGR -24.5%

Valuation

PE Ratio -0.83

Forward PE N/A

PEG Ratio 0.01

Forward PEG 0.01

PS Ratio 4.99

Forward PS N/A

PB Ratio -8.86

P/FCF Ratio N/A

P/Adj. FCF Ratio -8.52

P/OCF Ratio -21.64

EV/Sales 5.27

EV/EBIT -2.07

EV/EBITDA -3.00

EV/FCF N/A

Earnings Yield -121.0%

FCF Yield 0.0%

Adj. FCF Yield -11.7%

Financial Health

Net Debt $125K

Total Debt $269K

Cash & Short-Term Investments $144K

Total Assets $166K

Current Ratio 0.40

Quick Ratio 0.40

Debt / Equity Ratio -1.06

Debt / EBITDA -0.34

Debt / FCF N/A

OCF / Debt 0.00

Interest Coverage -241.14

Altman Z-Score -1,415.57

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin -481.6%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin 0.0%

Adj. FCF Margin -58.5%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -4198.2%

Return on Equity -269.0%

Return on Invested Capital -11253.3%

Return on Capital Employed 664.6%

Return on Tangible Assets -4198.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 150.0%

Revenue CAGR 5Y 100.0%

Revenue CAGR 10Y 54.5%

EPS CAGR 3Y 13.8%

EPS CAGR 5Y 2.5%

EPS CAGR 10Y 28.1%

FCF CAGR 3Y -14.0%

FCF CAGR 5Y -6.8%

FCF CAGR 10Y 46.2%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $0

Free Cash Flow $0

Adj. Free Cash Flow $-264K

FCF Per Share -$0.11

OCF Per Share -$0.11

OCF/S Ratio 0.0%

Income Statement

Revenue $451K

Gross Profit $119K

Operating Income $-2.17M

EBITDA $-791.25K

Net Income $-1.03M

EPS (Diluted) -$2.88

Revenue / Employee $45.1K

Profit / Employee $-102.7K

Employees 10